A randomized, parallel group design study evaluating the efficacy and safety of Mucosta ophthalmic suspension UD2% compared to Soft Santear (artificial tear) in dry eye patients complicated with glaucoma.
- Conditions
- Dry eye
- Registration Number
- JPRN-UMIN000009930
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
(a)Patients with intraocular pressure greater than the target(Refer to the third edition of glaucoma clinical practice guidelines). (b)Patients with anterior eye disease(including blepharitis, lagophthalmos, blepharospasm and iritis) other than dry eye.(Except for history) (c)Patients who had ocular administration of treatment for corneal-conjunctival epithelial disorder or dry eye within two weeks prior to the initiation of the study. (d)Patients who currently have punctal plugs, have had removal of punctal plug(s) or whose punctal plug(s) fell out within 3 months prior to the initiation of the study, or patients with a history of surgical punctal occlusion. (e)Patients who cannot suspend the use of contact lenses or who expect to use contact lenses. (f)Patients who are pregnant, suspected to be pregnant or patients who are breastfeeding. (g)Patients with hypersensitivity to ingredients of the study drugs and test reagents used in this study. (h)Patients who are judged by the investigator to be inappropriate for the study because of a past or concurrent systemic disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fluorescein cornea staining score
- Secondary Outcome Measures
Name Time Method